Grace Therapeutics (GRCE) Q4 2023 Earnings Report

1,210 Followers

GRCE Q4 2023 EPS Results

Actual EPS: -$3.90
Consensus EPS: -$0.84
Beat/Miss: Missed by -$3.06
One Year Ago EPS: -$0.54

GRCE Q4 2023 Revenue Results

Actual Revenue: $0
Expected Revenue: $0
Beat/Miss: Met expectations
YoY Revenue Growth: ―

Earnings Announcement Details

Quarter: Q4 2023
Date: 06/23/2023
Time: Before Open
Conference Call: Friday, June 23, 2023

GRCE Upcoming Earnings

Grace Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

GRCE Earnings History

GRCE earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Nov 16, 2026	2027 (Q2)	-0.15-	-0.06	―	―
Aug 13, 2026	2027 (Q1)	-0.13-0.91	-0.21	-333.33% (-0.70)
Jun 18, 2026	2026 (Q4)	-0.23-0.06	0.11	-154.55% (-0.17)
Feb 12, 2026	2026 (Q3)	-0.28-0.14	-0.36	61.11% (+0.22)
Nov 13, 2025	2026 (Q2)	-0.25-0.06	-0.3	80.00% (+0.24)
Aug 12, 2025	2026 (Q1)	-0.22-0.21	-0.24	12.50% (+0.03)
Jun 23, 2025	2025 (Q4)	-0.280.11	-0.17	164.71% (+0.28)
Feb 13, 2025	2025 (Q3)	-0.34-0.36	-0.21	-71.43% (-0.15)
Nov 13, 2024	2025 (Q2)	-0.37-0.30	-0.43	30.23% (+0.13)
Aug 09, 2024	2025 (Q1)	-0.27-0.24	-0.54	55.56% (+0.30)
Jun 21, 2024	2024 (Q4)	-0.35-0.17	-3.9	95.64% (+3.73)
Feb 12, 2024	2024 (Q3)	-0.23-0.21	-0.54	61.11% (+0.33)
Nov 13, 2023	2024 (Q2)	-0.26-0.43	-0.66	34.85% (+0.23)
Aug 11, 2023	2024 (Q1)	-0.28-0.54	-0.6	10.00% (+0.06)
Jun 23, 2023	2023 (Q4)	-0.84-3.90	-0.54	-622.22% (-3.36)
Feb 14, 2023	2023 (Q3)	-0.74-0.54	-0.54	0.00% (+0.00)
Nov 14, 2022	2023 (Q2)	―-0.66	-0.18	-266.67% (-0.48)
Aug 11, 2022	2023 (Q1)	―-0.60	-0.48	-25.00% (-0.12)
Jun 21, 2022	2022 (Q4)	-0.78-0.54	-1.44	62.50% (+0.90)
Feb 14, 2022	2022 (Q3)	-0.48-0.54	-1.44	62.50% (+0.90)
Nov 10, 2021	2022 (Q2)	―-0.18	-2.88	93.75% (+2.70)
Aug 12, 2021	2022 (Q1)	―-0.48	-2.4	80.00% (+1.92)
Jun 22, 2021	2021 (Q4)	―-1.44	10.56	-113.64% (-12.00)
Feb 09, 2021	2021 (Q3)	―-1.44	-6.52	77.91% (+5.08)
Nov 16, 2020	2021 (Q2)	―-2.88	-12.32	76.63% (+9.44)
Aug 13, 2020	2021 (Q1)	―-2.40	-5.41	55.65% (+3.01)
Jun 29, 2020	2020 (Q4)	―10.56	-1.1	1063.50% (+11.66)
Feb 14, 2020	2020 (Q3)	―-6.52	-2.52	-158.34% (-4.00)
Nov 13, 2019	2020 (Q2)	―-12.32	-22.49	45.22% (+10.17)
Aug 14, 2019	2020 (Q1)	―-5.41	-8.44	35.85% (+3.02)
Jun 26, 2019	2019 (Q4)	―-0.18	-1.93	90.50% (+1.74)
Feb 14, 2019	2019 (Q3)	―-0.42	-2.55	83.52% (+2.13)
Nov 14, 2018	2019 (Q2)	―-3.75	-1.94	-92.95% (-1.81)
Aug 14, 2018	2019 (Q1)	―-1.41	-1.19	-18.05% (-0.21)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Grace Therapeutics earnings date